An Evaluation of the Safety and Pharmacokinetics of Posaconazole (POS, SCH 56592) IV Solution via Peripheral Administration in Healthy Volunteers (P06356)
Completed
- Conditions
- Fungal infections10017528
- Registration Number
- NL-OMON36291
- Lead Sponsor
- Merck
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 96
Inclusion Criteria
Healthy male and female
Exclusion Criteria
Clinical significant abnormalities at medical research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Safety and tolerability</p><br>
- Secondary Outcome Measures
Name Time Method <p>Pharmacokinetics</p><br>